BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10847426)

  • 1. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
    Simioni P; Tormene D; Luni S; Caldato M; Girolami A
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutation.
    Halbmayer WM; Kalhs T; Haushofer A; Breier F; Fischer M
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):297-302. PubMed ID: 10456622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.
    Villani M; Tiscia GL; Margaglione M; Colaizzo D; Fischetti L; Vergura P; Grandone E
    J Thromb Haemost; 2012 Feb; 10(2):223-8. PubMed ID: 22136658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
    Federici EH; Al-Mondhiry H
    Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
    Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
    J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
    Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
    Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.
    Ehrenforth S; von Depka Prondsinski M; Aygören-Pürsün E; Nowak-Göttl U; Scharrer I; Ganser A
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):276-80. PubMed ID: 9974407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
    Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
    J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
    Martinelli I; Battaglioli T; De Stefano V; Tormene D; Valdrè L; Grandone E; Tosetto A; Mannucci PM;
    J Thromb Haemost; 2008 Mar; 6(3):494-8. PubMed ID: 18182035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Castoldi E
    Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.